More News! 10 Oct 2022
Positive data indicates likely therapeutic effect of Alzheimer’s drug
Positive phase 2a clinical data from an Alzheimer's disease (AD) biomarker study, has been announced today (October 10). Actinogen Medical Limited shared the news that its study validates its planned…